Miraca Holdings Inc (4544):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Miraca Holdings Inc (4544) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3487
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Miraca Holdings Inc (Miraca Holdings) is a holding company that operates through its business segments such as clinical laboratory testing, in vitro diagnostics and healthcare segment. The company develops, manufactures and sells diagnostic products that are used in medical field for early detection and diagnosis. Its clinical laboratory testing services include collecting consigned specimens of patients from medical institutions, conducting analyses and reporting the test results back. Miraca Holdings provides various healthcare related services, such as sterilization, clinical trial support and preventive medicine related services. It offers sterilization services to hospitals in the Kanto, Chubu, Kansai, Chugoku and Kyushu regions. Miraca Holdings is headquartered in Tokyo, Japan.

Miraca Holdings Inc (4544) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Miraca Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Miraca Holdings Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Miraca Holdings Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Miraca Holdings Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Miraca Holdings Inc, Medical Devices Deals, 2012 to YTD 2018 9
Miraca Holdings Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Miraca Holdings Inc, Pharmaceuticals & Healthcare, Deal Details 11
Private Equity 11
Avista Capital Partners Acquires Miraca Life Sciences from Miraca Holdings 11
Partnerships 13
Thermo Fisher Scientific Enters Into Licensing Agreement With Fujirebio For Procalcitonin 13
Baylor College to Form Joint Venture with Miraca 14
Miraca Holdings Inc – Key Competitors 15
Miraca Holdings Inc – Key Employees 16
Miraca Holdings Inc – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Joint Venture 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Miraca Holdings Inc, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Miraca Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Miraca Holdings Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Miraca Holdings Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Miraca Holdings Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Miraca Holdings Inc, Medical Devices Deals, 2012 to YTD 2018 9
Miraca Holdings Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Avista Capital Partners Acquires Miraca Life Sciences from Miraca Holdings 11
Thermo Fisher Scientific Enters Into Licensing Agreement With Fujirebio For Procalcitonin 13
Baylor College to Form Joint Venture with Miraca 14
Miraca Holdings Inc, Key Competitors 15
Miraca Holdings Inc, Key Employees 16
Miraca Holdings Inc, Subsidiaries 17
Miraca Holdings Inc, Joint Venture 17

List of Figures
Miraca Holdings Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Miraca Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Miraca Holdings Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Miraca Holdings Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Miraca Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Miraca Holdings Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Miraca Holdings Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Miraca Holdings Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Miraca Holdings Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Miraca Holdings Inc (4544):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Abivax SA (ABVX):企業の財務・戦略的SWOT分析
    Summary Abivax SA (Abivax) operates as a biotechnology company. It develops and commercializes anti-viral therapies and therapeutic vaccines for the treatment of infectious and viral diseases. The company’s pipeline products include ABX464, ABX544 and ABX196. Its ABX464 is an oral small molecule to …
  • Sinclair Oil Corporation:企業の戦略・SWOT・財務情報
    Sinclair Oil Corporation - Strategy, SWOT and Corporate Finance Report Summary Sinclair Oil Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • The Kiyo Bank Ltd:企業の戦略・SWOT・財務分析
    The Kiyo Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary The Kiyo Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • ASV Holdings, Inc. (ASV):企業の財務・戦略的SWOT分析
    ASV Holdings, Inc. (ASV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Ariste Medical LLC:医療機器:M&Aディール及び事業提携情報
    Summary Ariste Medical LLC (Ariste) is a medical device company that develops drug eluting surgical implants. The company develops drug eluting tunneled dialysis catheter for hemodialysis, drug eluting mesh for hernia repair, and drug eluting vascular graft for peripheral bypass. It also develops dr …
  • PUMA SE:企業の戦略・SWOT・財務情報
    PUMA SE - Strategy, SWOT and Corporate Finance Report Summary PUMA SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Kia Motors Corporation:企業の戦略・SWOT・財務情報
    Kia Motors Corporation - Strategy, SWOT and Corporate Finance Report Summary Kia Motors Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Prologis, Inc.:企業のM&A・事業提携・投資動向
    Prologis, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Prologis, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Domtar Corporation:戦略・SWOT・企業財務分析
    Domtar Corporation - Strategy, SWOT and Corporate Finance Report Summary Domtar Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Dana Gas (DANA):企業の財務・戦略的SWOT分析
    Summary Dana Gas is an oil and gas company that produces natural gas. The company carries out the exploration and production of gas, oil, and natural gas liquids. It offers processing, transportation, distribution, promotion and sales of petroleum and natural gas products. Dana Gas operates Sharjah …
  • BowLeven plc (BLVN):企業の財務・戦略的SWOT分析
    Summary BowLeven Plc (BowLeven) is an independent oil and gas exploration and production company. The company’s business activities include acquisition, exploration, and development of oil and gas properties. It holds equity interests in offshore and onshore exploration acreage in Cameroon and Gabon …
  • Atea ASA (ATEA):企業の財務・戦略的SWOT分析
    Atea ASA (ATEA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Spicers Ltd:企業の戦略的SWOT分析
    Spicers Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Inpex Corp (1605):企業の財務・戦略的SWOT分析
    Inpex Corp (1605) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Parex Resources Inc (PXT):石油・ガス:M&Aディール及び事業提携情報
    Summary Parex Resources Inc (Parex) is an oil and gas exploration and development company that acquires, explores, develops and produces crude oil and natural gas in South America and the Caribbean. The company holds interests in land base of 1.7 million gross acres over 22 blocks in Colombia's Llan …
  • Maxeda B.V.:企業の戦略・SWOT・財務情報
    Maxeda B.V. - Strategy, SWOT and Corporate Finance Report Summary Maxeda B.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Center Parcs (Holdings 1) Limited:企業の戦略・SWOT・財務情報
    Center Parcs (Holdings 1) Limited - Strategy, SWOT and Corporate Finance Report Summary Center Parcs (Holdings 1) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Episurf Medical AB (EPIS B):企業の財務・戦略的SWOT分析
    Summary Episurf Medical AB (Episurf Medical), formerly Diamorph Medtech AB is a medical technology company that provides patient-specific treatments of painful joint injuries. It offers diagnosis and design of implants and surgical instruments. Its products include Episealer Femoral Twin, Episealer …
  • Greenply Industries Ltd:企業の戦略・SWOT・財務情報
    Greenply Industries Ltd - Strategy, SWOT and Corporate Finance Report Summary Greenply Industries Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Tryton Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Tryton Medical Inc (Tryton Medical) is a medical device company that develops novel stent systems for the treatment of bifurcation lesions. The company provides tryton side branch coronary artery stent, which is designed to treat, protect and secure coronary bifurcations. Its tryton side bra …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆